Related Experiment Videos
Nonenzymatic glycation of transferrin: decrease of iron-binding capacity and increase of oxygen radical production
S Fujimoto1, N Kawakami, A Ohara
1Laboratory of Biochemistry, Kyoto Pharmaceutical University, Japan.
Biological & Pharmaceutical Bulletin
|March 1, 1995
Summary
Diabetic rats show reduced iron levels and binding capacity. Glycated transferrin, a protein altered by high blood sugar, loses its iron-binding ability and generates harmful oxygen radicals, contributing to diabetic complications.
Area of Science:
- Biochemistry
- Diabetic Complications
- Protein Chemistry
Background:
- Diabetes mellitus is associated with altered iron metabolism.
- Transferrin is the primary iron-transport protein in serum.
- Glycation of proteins is a hallmark of hyperglycemia and can alter protein function.
Purpose of the Study:
- To investigate the impact of glucose on transferrin's iron-binding capacity.
- To assess the production of oxygen radicals by glycated transferrin.
- To explore the functional consequences of transferrin glycation in diabetes.
Main Methods:
- Measurement of total iron-binding capacity (TIBC) and iron content in diabetic rat serum.
- In vitro incubation of human serum and purified transferrin with glucose.
- Assessment of unsaturated iron-binding capacity (UIBC) and iron content.
- Quantification of superoxide and hydroxyl radical production by glycated transferrin.
- Analysis of protein fragmentation using biochemical assays.
Main Results:
- Diabetic rat serum exhibited significantly lower TIBC and iron content compared to controls.
- In vitro glycation reduced the UIBC of human serum and apotransferrin.
- Glycated holotransferrin showed increased generation of superoxide and hydroxyl radicals.
- Glycated holotransferrin underwent fragmentation, unlike glycated apotransferrin.
Conclusions:
- Glycation impairs transferrin's iron-binding function.
- Glycated transferrin promotes the generation of reactive oxygen species (ROS).
- These findings suggest a role for glycated transferrin in the oxidative stress associated with diabetes.